Federated Hermes’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.83M | Sell |
56,351
-76
| -0.1% | -$11.4K | 0.01% | 714 |
|
|
2026
Q1 | $8.62M | Sell |
56,427
-962
| -2% | -$147K | 0.01% | 681 |
|
|
2025
Q4 | $7.91M | Buy |
57,389
+5,967
| +12% | +$781K | 0.01% | 693 |
|
|
2025
Q3 | $6.59M | Sell |
51,422
-48,181
| -48% | -$5.88M | 0.01% | 685 |
|
|
2025
Q2 | $12.1M | Sell |
99,603
-1,473
| -1% | -$166K | 0.02% | 527 |
|
|
2025
Q1 | $11.3M | Buy |
101,076
+12,821
| +15% | +$1.36M | 0.02% | 533 |
|
|
2024
Q4 | $8.59M | Sell |
88,255
-6,233
| -7% | -$665K | 0.02% | 585 |
|
|
2024
Q3 | $10.9M | Sell |
94,488
-3,448
| -4% | -$391K | 0.02% | 555 |
|
|
2024
Q2 | $10.4M | Sell |
97,936
-12,266
| -11% | -$1.23M | 0.02% | 546 |
|
|
2024
Q1 | $10.7M | Sell |
110,202
-9,853
| -8% | -$1.01M | 0.02% | 558 |
|
|
2023
Q4 | $12.1M | Sell |
120,055
-3,696
| -3% | -$357K | 0.03% | 516 |
|
|
2023
Q3 | $12.6M | Sell |
123,751
-2,935
| -2% | -$298K | 0.03% | 475 |
|
|
2023
Q2 | $12.8M | Sell |
126,686
-16,220
| -11% | -$1.62M | 0.03% | 489 |
|
|
2023
Q1 | $13.1M | Buy |
142,906
+6,387
| +5% | +$558K | 0.03% | 485 |
|
|
2022
Q4 | $12.4M | Sell |
136,519
-23,358
| -15% | -$1.97M | 0.03% | 494 |
|
|
2022
Q3 | $12.2M | Buy |
159,877
+16,398
| +11% | +$1.36M | 0.04% | 484 |
|
|
2022
Q2 | $12.1M | Sell |
143,479
-18,521
| -11% | -$1.62M | 0.03% | 510 |
|
|
2022
Q1 | $14.2M | Buy |
162,000
+64,879
| +67% | +$5.62M | 0.03% | 525 |
|
|
2021
Q4 | $8.49M | Sell |
97,121
-20,445
| -17% | -$1.7M | 0.02% | 691 |
|
|
2021
Q3 | $9.62M | Buy |
117,566
+8,369
| +8% | +$753K | 0.02% | 653 |
|
|
2021
Q2 | $9.96M | Buy |
109,197
+18,736
| +21% | +$1.67M | 0.02% | 660 |
|
|
2021
Q1 | $7.73M | Sell |
90,461
-1,592
| -2% | -$143K | 0.02% | 733 |
|
|
2020
Q4 | $8.69M | Sell |
92,053
-1,091
| -1% | -$95.3K | 0.02% | 679 |
|
|
2020
Q3 | $8.1M | Sell |
93,144
-2,824
| -3% | -$245K | 0.02% | 624 |
|
|
2020
Q2 | $8.38M | Sell |
95,968
-27,206
| -22% | -$2.35M | 0.02% | 588 |
|
|
2020
Q1 | $10.2M | Buy |
123,174
+63,830
| +108% | +$5.69M | 0.03% | 473 |
|
|
2019
Q4 | $5.62M | Sell |
59,344
-2,128
| -3% | -$191K | 0.01% | 739 |
|
|
2019
Q3 | $5.34M | Sell |
61,472
-1,465
| -2% | -$132K | 0.01% | 761 |
|
|
2019
Q2 | $5.75M | Sell |
62,937
-54,941
| -47% | -$4.65M | 0.01% | 742 |
|
|
2019
Q1 | $10.2M | Sell |
117,878
-53,415
| -31% | -$4.29M | 0.03% | 561 |
|
|
2018
Q4 | $13.2M | Sell |
171,293
-3,043
| -2% | -$237K | 0.04% | 408 |
|
|
2018
Q3 | $13.5M | Buy |
174,336
+36,837
| +27% | +$2.72M | 0.03% | 470 |
|
|
2018
Q2 | $9.31M | Sell |
137,499
-5,480
| -4% | -$378K | 0.03% | 470 |
|
|
2018
Q1 | $10.4M | Sell |
142,979
-131,195
| -48% | -$9.99M | 0.03% | 412 |
|
|
2017
Q4 | $20.6M | Buy |
274,174
+1,618
| +0.6% | +$122K | 0.06% | 247 |
|
|
2017
Q3 | $21M | Sell |
272,556
-34,109
| -11% | -$2.58M | 0.06% | 251 |
|
|
2017
Q2 | $22.9M | Sell |
306,665
-2,348,781
| -88% | -$166M | 0.07% | 251 |
|
|
2017
Q1 | $177M | Buy |
2,655,446
+526,324
| +25% | +$35.1M | 0.5% | 31 |
|
|
2016
Q4 | $139M | Buy |
2,129,122
+2,066,057
| +3,276% | +$134M | 0.42% | 43 |
|
|
2016
Q3 | $4.46M | Buy |
63,065
+5,408
| +9% | +$394K | 0.01% | 599 |
|
|
2016
Q2 | $4.26M | Buy |
57,657
+4,231
| +8% | +$292K | 0.01% | 597 |
|
|
2016
Q1 | $3.47M | Buy |
53,426
+2,363
| +5% | +$161K | 0.01% | 649 |
|
|
2015
Q4 | $3.94M | Sell |
51,063
-1,597
| -3% | -$127K | 0.01% | 636 |
|
|
2015
Q3 | $4.34M | Sell |
52,660
-27,971
| -35% | -$2.49M | 0.01% | 596 |
|
|
2015
Q2 | $7.11M | Buy |
80,631
+4,926
| +7% | +$452K | 0.02% | 529 |
|
|
2015
Q1 | $6.69M | Buy |
75,705
+27,189
| +56% | +$2.41M | 0.02% | 537 |
|
|
2014
Q4 | $4.03M | Buy |
48,516
+12,349
| +34% | +$1.02M | 0.01% | 696 |
|
|
2014
Q3 | $3.05M | Buy |
36,167
+17,972
| +99% | +$1.45M | 0.01% | 812 |
|
|
2014
Q2 | $1.48M | Buy |
18,195
+9,016
| +98% | +$709K | ﹤0.01% | 1057 |
|
|
2014
Q1 | $699K | Buy |
9,179
+769
| +9% | +$56K | ﹤0.01% | 1256 |
|
|
2013
Q4 | $606K | Buy |
8,410
+2,667
| +46% | +$185K | ﹤0.01% | 1284 |
|
|
2013
Q3 | $395K | Sell |
5,743
-217,177
| -97% | -$14.4M | ﹤0.01% | 1353 |
|
|
2013
Q2 | $14.1M | Buy |
+222,920
| New | +$14.5M | 0.06% | 268 |
|
Other funds holding NVS
Federated Hermes's NVS Position: Q2 2026 in Review
Federated Hermes reduced its Novartis (NVS) stake by 0.13% in Q2 2026, selling an estimated $11.4K and leaving 56,351 shares worth $8.83M. The position accounts for 0.01% of the portfolio, ranked #714.
Federated Hermes first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $177M in Q1 2017. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Federated Hermes held 56,351 shares of Novartis worth $8.83M as of Q2 2026.
- Federated Hermes sold 76 Novartis shares in Q2 2026, an estimated $11.4K.
- Novartis made up 0.01% of Federated Hermes's portfolio in Q2 2026, its #714 holding.
- Federated Hermes first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
- Federated Hermes's Novartis position peaked at $177M in Q1 2017.
- 1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.